Vaishali Pharma Statistics

Total Valuation

Vaishali Pharma has a market cap or net worth of INR 1.57 billion. The enterprise value is 1.68 billion.

Market Cap	1.57B
Enterprise Value	1.68B

Important Dates

The next estimated earnings date is Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Vaishali Pharma has 130.46 million shares outstanding. The number of shares has increased by 11.26% in one year.

Current Share Class	130.46M
Shares Outstanding	130.46M
Shares Change (YoY)	+11.26%
Shares Change (QoQ)	-5.53%
Owned by Insiders (%)	41.44%
Owned by Institutions (%)	1.53%
Float	76.39M

Valuation Ratios

The trailing PE ratio is 395.39.

PE Ratio	395.39
Forward PE	n/a
PS Ratio	1.50
PB Ratio	2.42
P/TBV Ratio	2.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	421.74
EV / Sales	1.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.91

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-1.31%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	38.78M
Profits Per Employee	147,259
Employee Count	27
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Vaishali Pharma has paid 2.93 million in taxes.

Income Tax	2.93M
Effective Tax Rate	42.44%

Stock Price Statistics

The stock price has decreased by -37.31% in the last 52 weeks. The beta is 0.36, so Vaishali Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-37.31%
50-Day Moving Average	12.34
200-Day Moving Average	13.96
Relative Strength Index (RSI)	46.65
Average Volume (20 Days)	431,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaishali Pharma had revenue of INR 1.05 billion and earned 3.98 million in profits. Earnings per share was 0.03.

Revenue	1.05B
Gross Profit	134.78M
Operating Income	-13.96M
Pretax Income	6.91M
Net Income	3.98M
EBITDA	-8.52M
EBIT	-13.96M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 18.43 million in cash and 123.18 million in debt, giving a net cash position of -104.76 million or -0.80 per share.

Cash & Cash Equivalents	18.43M
Total Debt	123.18M
Net Cash	-104.76M
Net Cash Per Share	-0.80
Equity (Book Value)	649.16M
Book Value Per Share	4.79
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 12.87%, with operating and profit margins of -1.33% and 0.38%.

Gross Margin	12.87%
Operating Margin	-1.33%
Pretax Margin	0.66%
Profit Margin	0.38%
EBITDA Margin	-0.81%
EBIT Margin	-1.33%
FCF Margin	n/a

Dividends & Yields

Vaishali Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.26%
Shareholder Yield	n/a
Earnings Yield	0.25%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 15, 2024. It was a forward split with a ratio of 10.

Last Split Date	Oct 15, 2024
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1